Paisi Ke (哌斯克)哌斯克
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 吉林省天泰药业股份有限公司Chinese legal name: 吉林省天泰药业股份有限公司
主要成分Active Ingredients
- 哌斯克主要成分:对乙酰氨基酚 伪麻黄碱Recorded Chinese composition: 哌斯克主要成分:对乙酰氨基酚 伪麻黄碱
- 对乙酰氨基酚acetaminophen
- 伪麻黄碱Weima Huangjian
药物知识说明
哌斯克主要成分:对乙酰氨基酚 伪麻黄碱是一种在国家药监局注册认定的药品。该药品含有伪麻黄碱、对乙酰氨基酚-643e0306等成分。
该药品关联的活性成分包括：伪麻黄碱Weima Huangjian、对乙酰氨基酚acetaminophen。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：吉林省天泰药业股份有限公司Chinese legal name: 吉林省天泰药业股份有限公司。
您可以探索含有相同成分的其他药品：伪麻黄碱-34ee3fb7成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 哌斯克) is a medicine registered with the national drug regulatory authority. It contains paracetamol and other recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 伪麻黄碱Weima Huangjian, 对乙酰氨基酚acetaminophen.
Manufacturers recorded for this product: 吉林省天泰药业股份有限公司Chinese legal name: 吉林省天泰药业股份有限公司.
Explore other medicines containing the same ingredient: 伪麻黄碱 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 哌斯克Recorded Chinese name: 哌斯克
- 规格Specification: 哌斯克为复方制剂，12粒装。Recorded Chinese composition: 哌斯克为复方制剂，12粒装。
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 吉林省天泰药业股份有限公司Chinese legal name: 吉林省天泰药业股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H10970311
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H10970311
Manufacturer
Chinese legal name: 吉林省天泰药业股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H10970311
生产企业
吉林省天泰药业股份有限公司(国产)
适应症
哌斯克用于感冒引起的发热、头痛、周身四肢酸痛、喷嚏、流涕、鼻塞等症状。
用法用量
口服。成人一次1~2粒，一日3次。或遵医嘱。
不良反应
偶见轻度恶心、上腹不适、头晕等。
禁忌
对哌斯克组成成分过敏者禁用。
注意事项
1.服用量每日不得超过8粒，疗程不超过7天。超量服用可造成头晕，失眠及精神症状。|2.心脏病，高血压，甲亢，青光眼，肺气肿等肺部疾病引起呼吸困难患者，前列腺肥大伴排尿困难患者不宜服用。|3.服用若症状未见改善或出现高热，应及时停药。
贮藏
密封保存。
规格
哌斯克为复方制剂，12粒装。
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.